SCHEMBL13359405

SCHEMBL13359405

CCOC(=O)OC1=C(c2c(C)cc(-c3ccc(Cl)cc3)cc2C)C(=O)CC=C1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.36
ALPL P05186 1/20 0.36
TARBP2 Q15633 1/20 0.34
PTGES O14684 1/20 0.34
ALOX5 P09917 1/20 0.34
MAPT P10636 5/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
GAA P10253 1/20 0.33
TRPM8 Q7Z2W7 1/20 0.33
APP P05067 1/20 0.33
KDM4E B2RXH2 2/20 0.33
HRH2 P25021 1/20 0.33
HRH1 P35367 1/20 0.33
PRKCZ Q05513 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
TP53 P04637 1/20 0.33
MDM2 Q00987 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL823017 0.83 KMT2A (0.34) LMNASMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL811968 0.77 LMNA (0.47) LMNAALPLMAPTHRH2HRH1
SCHEMBL812048 0.76 LMNA (0.38) LMNAALPLMAPTSMN1; SMN2GAA
SCHEMBL811965 0.74 LMNA (0.37) LMNAALPLMAPTSMN1; SMN2GAA
SCHEMBL811909 0.73 ACACB (0.38) LMNAALPLPTGESALOX5MAPT
SCHEMBL811937 0.71 MEN1 (0.34) LMNAALPLPTGESALOX5MAPT
SCHEMBL6222370 0.70 ALPL (0.43) LMNAALPLTARBP2PTGESALOX5
SCHEMBL2759798 0.68 ACACB (0.42) LMNAMAPTSMN1; SMN2KDM4EHRH2
SCHEMBL7572578 0.67 RXRA (0.45) LMNAALPLMAPTGAAKDM4E
SCHEMBL14405335 0.67 HRH2 (0.34) LMNAMAPTSMN1; SMN2GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7718706-B2 Arylphenyl-substituted cyclic keto-enols BAYER AKTIENGESELLSCHAFT (DE) 2010-05-18 US disclosed
US-20100087320-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO-ENOLS LIEB FOLKER 2010-04-08 US disclosed
US-20080081807-A1 Arylphenyl-substituted cyclic keto-enols LIEB FOLKER 2008-04-03 US disclosed
US-7288676-B2 Arylphenyl-substituted cyclic ketoenols BAYER CROPSCIENCE AG (DE) 2007-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081807-A1 Arylphenyl-substituted cyclic keto-enols KCNE1, DDT, KCNQ3 LMNA 2176/4885ALPL 3069/4885TARBP2 3639/4885
US-20100087320-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO-ENOLS KCNE1, DDT, KCNQ3 LMNA 2176/4885ALPL 3069/4885TARBP2 3639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.